Autonomic nervous system response to L-Dopa in patients with advanced Parkinson’s disease

37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Milano, Italy, August 25-29, p. 6162-6165, 2015. Engineering in Medicine and Biology Society Proceedings – V. Ruonala, M. Tarvainen, P. Karjalainen, E. Pekkonen, S. Rissanen

Levodopa is the main treatment method for reducing the symptoms of Parkinson's disease. Whereas it reduces the motor symptoms efficiently, its effect on autonomous nervous system is not clear. The information about effect of levodopa on heart rate variability is not coherent between the studies. In this study, ECG of 11 patients with Parkinson's disease was measured during levodopa challenge with pronounced dose of fast release levodopa to ensure the positive drug effect for deep brain stimulation treatment. Heart rate variability analysis was done at three time points, before administration of levodopa, 30 and 60 minutes after administration. After 30 minutes of administration, the HRV parameters show that parasympathetic nervous system activity is decreased and the sympatho-vagal balance is shifted towards sympathetic control. At 60 minutes after administration the parasympathetic nervous system activates slightly and causes a decrease in heart rate.

Previous
Previous

Signal features of surface electromyography in advanced Parkinson’s disease during different settings of deep brain stimulation

Next
Next

Dynamic tension EMG to characterize the effects of DBS treatment of advanced Parkinson’s disease